| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040171006 Comprises nucleotide sequences coding enzymatic polypeptide treatment and prevention of cancers, nervous system, urogenital, hematological and gastro-intestinal disorders |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170997 used in drug screening for preventing or treating diseases associated with abnormalities in intracellular signal transduction; genetic engineering |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170993 Methods for diagnosing and treating heart disease |
| 09/02/2004 | US20040170979 Dna encoding l-ribose isomerase and uses thereof |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170972 comprises DNA vaccine, a recombinant vaccine, and a T cell epitope vaccine; includes use of serological diagnosis; genetic engineering |
| 09/02/2004 | US20040170971 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis |
| 09/02/2004 | US20040170969 GRF2 binding proteins and applications thereof |
| 09/02/2004 | US20040170961 for drug screening anticancer agents; solid phase synthesis; animal models; genetic engineering; kits |
| 09/02/2004 | US20040170653 recognised by CD8-positive cytotoxic T-lymphocytes as a peptide antigen and causes a CTL-induced lysis and/or apoptosis of tumor or leukemia cell; has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein |
| 09/02/2004 | US20040170652 Saponin inactivated mycoplasma vaccine |
| 09/02/2004 | US20040170649 uses optimal solvent systems such that the lipid envelope around the viral particle is dissolved while the viral particle remains intact; autologous vaccines |
| 09/02/2004 | US20040170609 Biological control of nematodes |
| 09/02/2004 | DE202004009310U1 Anlage zur Anwendung einer Klimaschutztechnologie durch maximierte Nettoproduktion von Sauerstoff System to apply a Climate Technology by maximizing net production of oxygen |
| 09/02/2004 | DE102004006526A1 Neues Lysindecarboxylase-Gen und Verfahren zur Herstellung von L-Lysin New lysine decarboxylase gene, and methods for producing L-lysine |
| 09/02/2004 | CA2843744A1 Delta-endotoxin genes and methods for their use |
| 09/02/2004 | CA2824150A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2824126A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2753408A1 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | CA2516971A1 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/02/2004 | CA2516550A1 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | CA2516520A1 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 09/02/2004 | CA2514460A1 Novel vector |
| 09/01/2004 | EP1452597A1 Method of activating protein |
| 09/01/2004 | EP1452591A1 Fluorescent protein |
| 09/01/2004 | EP1452588A1 Reductase gene and use of the same |
| 09/01/2004 | EP1452585A1 Gamma-glutamylcysteine-producing yeast and method of screening the same |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452541A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 09/01/2004 | EP1451856A2 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| 09/01/2004 | EP1451579A2 Method of using a non-antibody protein to detect and measure an analyte |
| 09/01/2004 | EP1451370A2 Chromosomal saturation mutagenesis |
| 09/01/2004 | EP1451344A2 Compositions and methods for use in isolation of nucleic acid molecules |
| 09/01/2004 | EP1451337A2 Nogo receptor-mediated blockade of axonal growth |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451330A1 Methods of preparing a targeting vector and uses thereof |
| 09/01/2004 | EP1451328A2 Phytases and method for producing these phytases |
| 09/01/2004 | EP1451324A2 G-protein coupled receptor lustr2 and uses thereof |
| 09/01/2004 | EP1451322A2 Il-21 antagonists |
| 09/01/2004 | EP1451313A2 Method for cloning and expression of bseri restriction endonuclease and bseri methylase in e. coli |
| 09/01/2004 | EP1451307A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/01/2004 | EP1451297A1 Phenotypic screen of chimeric proteins |
| 09/01/2004 | EP1451293A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 09/01/2004 | EP1451292A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted |
| 09/01/2004 | EP1451223A2 Expression control using variable intergenic sequences |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451221A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 09/01/2004 | EP1451219A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 09/01/2004 | EP1451217A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| 09/01/2004 | EP1451215A2 Method to isolate genes involved in aging |
| 09/01/2004 | EP1451213A2 Human and murine cytokine polypeptides |
| 09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
| 09/01/2004 | EP1451151A1 Hydroperylene derivatives |
| 09/01/2004 | EP1450959A2 Apparatus and method for rapid disruption of cells or viruses |
| 09/01/2004 | EP1450752A2 Multivalent streptococcal vaccine compositions and methods for use |
| 09/01/2004 | EP1450626A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate |
| 09/01/2004 | EP1450613A2 Liquid yeast compositions |
| 09/01/2004 | EP1450610A2 Probiotic compositions |
| 09/01/2004 | EP1450604A2 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
| 09/01/2004 | EP1042482B1 Acetyl-coa-carboxylase from candida albicans |
| 09/01/2004 | EP0937139B1 Amidase |
| 09/01/2004 | EP0772627B1 Production of biologically active recombinant neurotrophic protein |
| 09/01/2004 | EP0769057B1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 09/01/2004 | CN1526021A Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
| 09/01/2004 | CN1526019A Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 09/01/2004 | CN1526017A Gene associated with leishmania parasite virulence |
| 09/01/2004 | CN1526013A Lipolytic enzyme genes |
| 09/01/2004 | CN1526010A Bacterial host strains |
| 09/01/2004 | CN1525981A T1R taste receptors and genes encoding same |
| 09/01/2004 | CN1525862A Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 09/01/2004 | CN1524962A Microorganism catalysis method for producing acrylamide |
| 09/01/2004 | CN1524961A Microorganism continuous catalysis method for producing acrylamide |
| 09/01/2004 | CN1524959A Method for producing gene engineering recombination 192 peptide human growth hormone |
| 09/01/2004 | CN1524956A Method for producing l-lysine |
| 09/01/2004 | CN1524950A Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof |
| 09/01/2004 | CN1524949A Oxalic acid penicillium, bacterial preparation thereof and its preparation method, and the application of the preparation in dephosphorization, prophylaxis and soil fertility enhancement |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1164763C Biological fermentation culture medium substrate and its preparation method |
| 09/01/2004 | CN1164761C Process for producing product contg. antihypertensive tripeptides |
| 09/01/2004 | CN1164755C Method of improving soluble expression of foreign gene in colon bacillus |
| 09/01/2004 | CN1164738C Insect pestilence germ and method of application for breeding destroy intestinal worms |
| 09/01/2004 | CN1164737C Preparing gamma-poly glutamic acid, glutamate, glutathione and its precursor with bacillus subtilis NX-2 |
| 09/01/2004 | CN1164736C Method for producing D-a amino acid series by using De's bacterium JS-02 of Bakehuo in onions |
| 09/01/2004 | CN1164735C Spore lactobacillus and its culture process and application |
| 09/01/2004 | CN1164734C Spore lactobacillus and its culture process and application |
| 09/01/2004 | CN1164733C Efficient Bt15A3 strain with excellent gene organization and its separation and application |
| 09/01/2004 | CN1164509C Biofuel cell using wastewater and active sludge for wastewater treatment |
| 08/31/2004 | US6784164 Choline binding proteins for anti-pneumococcal vaccines |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783967 Which encode the beta-subunit of rna polymerase b |
| 08/31/2004 | US6783966 For diagnosis and treatment of diseases; for production of glycolipids |
| 08/31/2004 | US6783962 Particulate material for purification of bio-macromolecules |
| 08/31/2004 | US6783960 Polypeptide for use in the treatment of thrombosis and sepsis |
| 08/31/2004 | US6783959 Cd antigens for diagnosis/therapy |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |